Non Traumatic Neuro-Vascular Diseases Critical Complications : a Prospective Cohort Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Collection of medical data.
- Who it may be relevant to
- Registry conditions: Non Traumatic Acute Brain Injury. Basic parameters: from 15 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Prospective Cohort of Patients Hospitalized in West French Intensive Care Units.
Overview
The purpose of this observational epidemiological study is to investigate the management and the complications associated with Non Traumatic Neuro-Vascular Diseases. Data will be analysed to answer pre-defined scientific projects and to improve management of these conditions.
Detailed description
Anonymous data will be collected by study coordinators in a secured e-database. Cross audit will be performed to check data.
Interventions
- Other Collection of medical data
A code will be applied to each patient included. Medical data such as demography, Simplified Acute Physiological Score II (SAPS II), Sequential Organ Failure Assessment (SOFA), procedures and complications during ICU stay will be collected.
Primary outcome measures
- in ICU stay complications [Time frame: Within the first 28 days after ICU admission date]
Secondary outcome measures (2)
- Duration in mechanical ventilation [Time frame: in ICU (up to 90 days)]
- ICU length of stay [Time frame: in ICU (up to 90 days)]
Eligibility criteria
Inclusion criteria
- Non Traumatic Neuro-Vascular Diseases
Exclusion criteria
- Consent withdrawal
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
France · 6 centers
- Angers University Hospital — Angers
- CHU de Brest La Cavale Blanche — Brest
- Nantes University Hospital — Nantes
- Poitiers University Hospital — Poitiers
- Rennes University Hospital — Rennes
- Tours University Hospital — Tours
Identifiers
NCT: NCT02714387 · RC12_0207 cohorte fiche 1